Accesswire
24 Sept 2026, 20:45 UTC · 7w ago
Utah Medical Products, Inc. Commences Tender Offer
Impact · against what's priced in
UTMD is initiating a tender offer at $75.00 per share, creating a price floor and signaling management's belief that the stock is undervalued relative to industry multiples. However, this bullish signal is partially offset by a reported 12% decline in sales and 13% drop in net profits for H1 2026.
- UTMD+0.20
No priced-in read yet
- In context
The company is offering to buy back up to 650,000 shares at $75.00, a price the CEO claims is still below a fair value of $90.00, though recent H1 2026 sales and profits fell by 12% and 13% respectively.
Read from the article alone
Search tags
